Showing results (731-740 of 6,300) with videos related to
Sort By:
Pageof 630
Diabetes, Obesity & Metabolism|September 10, 2014
Control of brain development and homeostasis by local and systemic insulin signallingJ Liu, P Spéder, A H BrandDiabetes, Obesity & Metabolism|September 10, 2014
Imaging of the islet neural networkS-C Tang, S-J Peng, H-J ChienDiabetes, Obesity & Metabolism|September 10, 2014
Neural regulation of pancreatic islet cell mass and functionB ThorensDiabetes, Obesity & Metabolism|September 10, 2014
Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1,324,515 patients from observational studiesT Wang, F Wang, Z Gou, et al.Diabetes, Obesity & Metabolism|October 18, 2014
Is insulin the most effective injectable antihyperglycaemic therapy?J B Buse, A Peters, D Russell-Jones, et al.Diabetes, Obesity & Metabolism|July 26, 2014
Role of γ-aminobutyric acid signalling in the attenuation of counter-regulatory hormonal responses after antecedent hypoglycaemia in healthy menJ Klement, B Mergelkuhl, J Born, et al.Diabetes, Obesity & Metabolism|July 26, 2014
Effect of sitagliptin therapy on triglyceride-rich lipoprotein kinetics in patients with type 2 diabetesA J Tremblay, B Lamarche, I Kelly, et al.Diabetes, Obesity & Metabolism|July 26, 2014
Two novel glucagon receptor antagonists prove effective therapeutic agents in high-fat-fed and obese diabetic miceF P M O'Harte, Z J Franklin, N IrwinDiabetes, Obesity & Metabolism|July 22, 2014
The interleukin-1 receptor antagonist anakinra improves first-phase insulin secretion and insulinogenic index in subjects with impaired glucose toleranceP C M van Poppel, E J P van Asseldonk, J J Holst, et al.Diabetes, Obesity & Metabolism|July 22, 2014
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controlsC A Bannister, S E Holden, S Jenkins-Jones, et al.Pageof 630